The Long-Term Outlook for Mogamulizumab in Previously Treated Cutaneous T-Cell Lymphoma

The results of a follow-up analysis to the phase III  MAVORIC study were presented at the ASH 2018 Annual Meeting& Exposition.

Source: CancerNetwork - December 6, 2018 Category: Cancer & Oncology Authors: Traci DeVito Source Type: news